Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-12-05
2010-12-14
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253110, C544S121000, C544S374000
Reexamination Certificate
active
07851471
ABSTRACT:
The present application relates to new compounds of formula (I),to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
REFERENCES:
patent: 2009/0176798 (2009-07-01), Boyd et al.
patent: 2009/0203695 (2009-08-01), Higginbottom et al.
patent: 2009/0281087 (2009-11-01), Boyd et al.
patent: 0933361 (1999-08-01), None
patent: 1 787 679 (2007-05-01), None
patent: 2001-131149 (2001-05-01), None
patent: 2001-261657 (2001-09-01), None
patent: WO97/46585 (1997-12-01), None
patent: WO02/26723 (2002-04-01), None
patent: WO2005/016902 (2005-02-01), None
patent: WO2006/072393 (2006-07-01), None
patent: WO2007/022257 (2007-02-01), None
patent: WO2007/025613 (2007-03-01), None
patent: WO2007/098939 (2007-09-01), None
patent: WO2009/071668 (2009-06-01), None
patent: WO2009/147211 (2009-12-01), None
patent: WO2009/147216 (2009-12-01), None
patent: WO2009/147219 (2009-12-01), None
patent: WO2009/147221 (2009-12-01), None
International Search Report dated Jun. 19, 2009 for International Appln. No. PCT/EP2008/066899 (International Publication No. W02009/071668), 2 pgs.
International-Type Search Report for Swedish Patent Appln. No. 0702697-4 dated Jun. 25, 2008, 8 pgs.
STN International Registry File, RN 913515-85-2 (Entry date Nov. 17, 2006), RN: 775282-94-5 (Entry date Nov. 5, 2006).
Banks, W.A. et al,Brain Res.(2002), 950:130-136.
Bouloumie A, et al,Circ. Res.(1998), 83-1059-1066.
Browning et al,Metabolism(2004), 53: 899-903.
Bryson, J.M.,Diabetes, Obesity and Metabolism(2000), 2: 83-89.
Gonzalez et al,Neuroendocrinology(1999), 70: 213-220.
Gorden P, et al,Current Opinion in Pharmacology(2003), 3: 655-659.
Hanew,Eur. J. Endocrin.(2003), 149: 407-412.
Kastin, A.J.,Peptides(1999), 20: 1449-1453.
Kinsella et al,BMC Pharm(2004), 4:17, 1-13.
Koistinen et al,Eur. J. Clin. Invest.(1998), 28: 894-897.
Lu et al,Proc. Nat. Acad. Sci., (2006), 103: 1593-1598.
Lyon, C.J. et al,Endocrinol. (2003), 144: 2195-2200.
Maachi et al,Int. J. Obes. Relat. Metab. Disord. (2004), 28: 993-997.
Mangge et al,Exp. Clin. Endocrinol. Diabetes(2004), 112: 378-382.
Mantzoros, C.S.,Ann. Intern. Med. (1999), 130-671-680.
Mirshamsi et al,Regulatory Peptides(2007), 141:19-24.
Mirshamsi et al,J. Neuroendocrinology(2005), 17, 246-254.
Otero, M. et al,FEBS Lett(2005), 579: 295-301.
Samson et al,Endocrinol. (1996), 137: 5182-5185.
Somasundar P. et al,J. Surg. Res. (2004), 116: 337-349.
Suganami E. et al,Diabetes(2004), 53: 2443-2448.
Van Heek et al,J. Clin. Invest. (1997), 99:385-390.
Zarkesh-Esfahani, H et al,J. Immunol. (2001), 167: 4593-4599.
Boyd Joseph W.
Brown Giles A.
Higginbottom Michael
AstraZeneca AB (PUBL)
Fish & Richardson P.C.
Hui San-ming
Zarek Paul
LandOfFree
Compounds I does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds I, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds I will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4206774